Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis

Improved surgical outcomes for hilar cholangiocarcinoma: changes in surgical procedures and related outcomes based on 40 years of experience at a single institution

(2015) Ryota Higuchi et al.   SURGERY TODAY

Pharmacokinetic Study of Adjuvant Gemcitabine Therapy for Biliary Tract Cancer following Major Hepatectomy (KHBO1101)

(2015) Yutaka Fujiwara et al.   PLoS One

Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study

(2014) Shogo Kobayashi et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Assessment of Nodal Status for Perihilar Cholangiocarcinoma

(2013) Taro Aoba et al.   ANNALS OF SURGERY

Hepatopancreatoduodenectomy for Cholangiocarcinoma

(2012) Tomoki Ebata et al.   ANNALS OF SURGERY

Clinical Significance of Left Trisectionectomy for Perihilar Cholangiocarcinoma

(2012) Seiji Natsume et al.   ANNALS OF SURGERY

Evolution of Surgical Treatment for Perihilar Cholangiocarcinoma

(2012) Masato Nagino et al.   ANNALS OF SURGERY

Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma

(2012) John P. Neoptolemos et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis

(2012) Anne M. Horgan et al.   JOURNAL OF CLINICAL ONCOLOGY

A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures

(2011) Takeshi Takahara et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

(2011) Peter C. Austin   MULTIVARIATE BEHAVIORAL RESEARCH

Hepatectomy With Simultaneous Resection of the Portal Vein and Hepatic Artery for Advanced Perihilar Cholangiocarcinoma

(2010) Masato Nagino et al.   ANNALS OF SURGERY

Adjuvant Gemcitabine Plus S-1 Chemotherapy Improves Survival After Aggressive Surgical Resection for Advanced Biliary Carcinoma

(2009) Yoshiaki Murakami et al.   ANNALS OF SURGERY

Clinicopathologic Study of Cholangiocarcinoma With Superficial Spread

(2009) Tsuyoshi Igami et al.   ANNALS OF SURGERY

Gemcitabine-Based Adjuvant Chemotherapy Improves Survival After Aggressive Surgery for Hilar Cholangiocarcinoma

(2009) Yoshiaki Murakami et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Surgical treatment of hilar cholangiocarcinoma in the “new era”: the Nagoya University experience

(2009) Tsuyoshi Igami et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds

(2009) Alastair L. Young et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience

(2009) Sung Gyu Lee et al.   Journal of Hepato-Biliary-Pancreatic Sciences

D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer

(2008) Mitsuru Sasako et al.   NEW ENGLAND JOURNAL OF MEDICINE